Clinical trial Recruiting at 1 site Observational Ages 18 to 45 Women only

AI into Ultrasound Diagnostics in Reproductive Medicine

Official title: Innovation for Women's Health: the Integration of Artificial Intelligence in the Diagnostic Ultrasound Assessment of Reproductive Medicine

Run by Semmelweis University · NCT07810920 · Data updated 2026-11-12

Researchers are testing AI tools that analyze transvaginal ultrasound images to help detect endometriosis, adenomyosis, uterine masses, and pregnancy-related receptivity in women aged 18-45.

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment1600 (estimated)
SponsorSemmelweis University
Academic / other
Locations1 site (Budapest, Budapest)
StatusRecruiting
StartedSeptember 1, 2026
Main results expectedMay 31, 2030
Study endsDecember 31, 2030
Registry record updatedSeptember 18, 2026
Trial IDNCT07810920 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18-45 with clinical suspicion of endometriosis or adenomyosis, or with suspected uterine anomalies, leiomyomas planned for treatment, or IVF candidates undergoing ultrasound evaluation.

Probably not a fit

Patients whose conditions fall outside the imaging or AI analysis scope may not see a direct benefit from AI-based assessments.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop and validate artificial intelligence–based algorithms that can aid ultrasound diagnosis of endometriosis, adenomyosis, myometrial masses, uterine malformations, and endometrial receptivity. Algorithms will be trained and tested on standardized transvaginal ultrasound images obtained during routine exams. The study will also explore whether AI features can predict histological characteristics of myometrial masses and the likelihood of successful outcomes in assisted reproduction. Participants are women with suspected endometriosis or adenomyosis, uterine abnormalities, leiomyomas planned for surgery, or those undergoing IVF, recruited at Semmelweis University in Budapest. No interventions are described beyond ultrasound imaging with AI analysis as part of the observational framework.

Why it matters

Potential benefit: If successful, AI-assisted ultrasound could improve accuracy and speed of uterine and endometriosis diagnoses and help predict IVF outcomes.

How similar studies have gone: Previous imaging studies using AI in gynecology have shown promise, but this application to real-time ultrasound diagnosis in reproductive medicine remains exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women aged 18-45 years with clinical suspicion of endometriosis or adenomyosis, in whom the diagnosis of endometriosis is subsequently confirmed, including peritoneal, ovarian, and deep infiltrating endometriosis. The diagnosis is established by imaging, laparoscopy, or laparotomy, based on characteristic intraoperative findings and histological analysis (#Enzian classification).
* Women undergoing ultrasound examination for suspected congenital uterine anomaly or other intracavitary uterine pathology.
* Women with previously confirmed leiomyoma scheduled for surgical treatment.
* Women scheduled for IVF treatment or embryo transfer.
* Willingness and capacity to provide written informed consent prior to enrolment.

Exclusion Criteria:

* TVUS is not technically feasible.
* Postmenopausal status.
* Pregnancy.
* Puerperium (up to 3 months postpartum).
* Suspected premalignancy, or presence or history of malignancy.
* Chronic comorbidities, including uncontrolled diabetes mellitus, severe cardiovascular or respiratory disease, systemic autoimmune disease, or uncontrolled thyroid dysfunction.
* Other conditions, including psychiatric illness or substance use, and any circumstance in which study participation could pose a risk to the patient, or in which enrolment could bias the study results.
* For the endometrial receptivity sub-study, confirmed uterine or endometrial pathology other than adenomyosis.

Where it's running

  • Department of Obstetrics and Gynecology, Semmelweis University
    Budapest, Budapest, Hungary
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.